Opus Genetics, Inc. Cash Flow Quality Index
Opus Genetics, Inc. cash flow quality index. Opus Genetics, Inc. (IRD) has a Cash Flow Quality Index of -0.54x as of September 2023. Operating cash flow of $-3.00 Million is below net income of $5.56 Million, suggesting accrual-heavy earnings not yet converted to cash. See IRD financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Opus Genetics, Inc. (2022–2022)
Cash flow quality index of Opus Genetics, Inc. from 2022 to 2022. Historical Cash Flow Quality Index for Opus Genetics, Inc. across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Opus Genetics, Inc. (IRD) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Opus Genetics, Inc. Cash Flow Quality Index by Year (2022–2022)
Opus Genetics, Inc. cash flow quality index by year from 2022 to 2022. Year-by-year earnings quality comparison for Opus Genetics, Inc.. For the full cash flow conversion analysis, see cash flow conversion of Opus Genetics, Inc..
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 0.80x | $14.31 Million | $17.89 Million | — |